A retired substance use prevention coalition director, Stephanie Strutner, MPH, owns and operates an independent consulting firm, Catalyst Evaluation Group, through which she provides support to clients through measuring impact and conducting biostatistical and epidemiological analyses. She also serves as Master Trainer for Community Anti-Drug Coalitions of America and serves as the part-time CEO for the Prevention Alliance of Tennessee.

Stephanie holds a Bachelor of Science degree in Biology from Emory & Henry University, a Master of Public Health degree in Health Policy and Management from the University of Tennessee with a focus and field practice in Epidemiology and Biostatistics, a Certificate in Social Enterprise Effectiveness from the College of Business Administration at the University of Tennessee, and is a Level II Certified Prevention Specialist.

Stephanie has spoken to the United States Congress on a number of occasions on the impact drug use has on our communities and has also testified before the Tennessee General Assembly on multiple pertinent prevention issues. In 2018, she was summoned to a meeting in the West Wing of the White House with the President of the United States to discuss effective opioid prevention strategies in local communities. In 2020, the efforts and impact of the coalition she led were selected to be showcased as a case study to Congress. Since 2023, she has been invited by the Institute for Research and Evaluation (UTRIP of Slovenia) to attend the United Nations Commission on Narcotics and Drugs, the global policy forum for drug policy, where she has presented on best practices for impact evaluation. She serves on the Board of Trustees for Emory & Henry University and on the International Board for the World Federation Against Drugs.